US Stock MarketDetailed Quotes

Korro Bio (KRRO)

Watchlist
  • 11.610
  • +1.080+10.26%
Close Jun 12 16:00 ET
  • 11.610
  • 0.0000.00%
Post 16:51 ET
167.45MMarket Cap-0.99P/E (TTM)

Korro Bio (KRRO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
181.46%6.39M
-43.11%1.29M
1.09M
1.46M
2.55M
2.27M
2.27M
0
0
Operating revenue
--0
181.46%6.39M
-43.11%1.29M
--1.09M
--1.46M
--2.55M
--2.27M
--2.27M
--0
--0
Cost of revenue
Gross profit
Operating expense
-25.88%20.44M
-0.47%93.73M
-32.14%17.18M
-12.73%20.33M
18.81%28.66M
28.51%27.57M
11.41%94.18M
-5.88%25.31M
21.64%23.29M
31.06%24.13M
Selling and administrative expenses
-4.42%7.49M
-7.81%28.16M
-25.86%6.19M
-11.20%6.51M
9.22%7.63M
-0.63%7.83M
11.95%30.55M
-27.22%8.35M
42.57%7.33M
32.30%6.99M
-General and administrative expense
-4.42%7.49M
-7.81%28.16M
-25.86%6.19M
-11.20%6.51M
9.22%7.63M
-0.63%7.83M
11.95%30.55M
-27.22%8.35M
42.57%7.33M
32.30%6.99M
Research and development costs
-34.39%12.95M
3.05%65.58M
-35.24%10.99M
-13.43%13.82M
22.72%21.03M
45.44%19.74M
11.15%63.64M
9.99%16.96M
13.96%15.96M
30.56%17.14M
Operating profit
18.32%-20.44M
4.97%-87.34M
31.06%-15.88M
17.41%-19.24M
-12.75%-27.2M
-16.63%-25.02M
-8.73%-91.91M
14.33%-23.04M
-21.64%-23.29M
-31.06%-24.13M
Net non-operating interest income expense
Other net income (expense)
-44.52%906K
-445.70%-29.28M
-1,824.43%-33.52M
-48.51%1.18M
-38.47%1.43M
-14.64%1.63M
149.93%8.47M
32.52%1.94M
248.17%2.28M
196.31%2.33M
Special income (charges)
----
---34.51M
----
----
----
----
--0
----
----
----
-Less:Restructuring and merger&acquisition
----
--3.63M
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
--30.89M
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
-44.52%906K
-38.23%5.23M
-49.07%990K
-48.51%1.18M
-38.47%1.43M
-14.64%1.63M
149.93%8.47M
32.52%1.94M
248.17%2.28M
196.31%2.33M
Income before tax
16.49%-19.53M
-39.77%-116.62M
-134.20%-49.41M
14.03%-18.06M
-18.23%-25.77M
-19.69%-23.39M
-2.83%-83.44M
17.03%-21.1M
-13.61%-21.01M
-23.69%-21.8M
Income tax
95K
351.77%637K
517.48%636K
0
-96.67%1K
0
422.22%141K
103K
-9K
11.11%30K
Net income
16.09%-19.63M
-40.30%-117.26M
-136.06%-50.04M
13.99%-18.06M
-18.07%-25.77M
-19.58%-23.39M
-2.97%-83.58M
16.62%-21.2M
-13.56%-21M
-23.67%-21.83M
Net income continuous Operations
16.09%-19.63M
-40.30%-117.26M
-136.06%-50.04M
13.99%-18.06M
-18.07%-25.77M
-19.58%-23.39M
-2.97%-83.58M
16.62%-21.2M
-13.56%-21M
-23.67%-21.83M
Minority interest income
Net income attributable to the parent company
16.09%-19.63M
-40.30%-117.26M
-136.06%-50.04M
13.99%-18.06M
-18.07%-25.77M
-19.58%-23.39M
-2.97%-83.58M
16.62%-21.2M
-13.56%-21M
-23.67%-21.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.09%-19.63M
-40.30%-117.26M
-136.06%-50.04M
13.99%-18.06M
-18.07%-25.77M
-19.58%-23.39M
-2.97%-83.58M
16.62%-21.2M
-13.56%-21M
-23.67%-21.83M
Basic earnings per share
32.13%-1.69
-33.19%-12.48
-135.40%-5.32
15.04%-1.92
-12.76%-2.74
-2.05%-2.49
82.35%-9.37
28.74%-2.26
2.21%-2.26
-10.17%-2.43
Diluted earnings per share
32.13%-1.69
-33.19%-12.48
-135.40%-5.32
15.04%-1.92
-12.76%-2.74
-2.05%-2.49
82.35%-9.37
28.74%-2.26
2.21%-2.26
-10.17%-2.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0181.46%6.39M-43.11%1.29M1.09M1.46M2.55M2.27M2.27M00
Operating revenue --0181.46%6.39M-43.11%1.29M--1.09M--1.46M--2.55M--2.27M--2.27M--0--0
Cost of revenue
Gross profit
Operating expense -25.88%20.44M-0.47%93.73M-32.14%17.18M-12.73%20.33M18.81%28.66M28.51%27.57M11.41%94.18M-5.88%25.31M21.64%23.29M31.06%24.13M
Selling and administrative expenses -4.42%7.49M-7.81%28.16M-25.86%6.19M-11.20%6.51M9.22%7.63M-0.63%7.83M11.95%30.55M-27.22%8.35M42.57%7.33M32.30%6.99M
-General and administrative expense -4.42%7.49M-7.81%28.16M-25.86%6.19M-11.20%6.51M9.22%7.63M-0.63%7.83M11.95%30.55M-27.22%8.35M42.57%7.33M32.30%6.99M
Research and development costs -34.39%12.95M3.05%65.58M-35.24%10.99M-13.43%13.82M22.72%21.03M45.44%19.74M11.15%63.64M9.99%16.96M13.96%15.96M30.56%17.14M
Operating profit 18.32%-20.44M4.97%-87.34M31.06%-15.88M17.41%-19.24M-12.75%-27.2M-16.63%-25.02M-8.73%-91.91M14.33%-23.04M-21.64%-23.29M-31.06%-24.13M
Net non-operating interest income expense
Other net income (expense) -44.52%906K-445.70%-29.28M-1,824.43%-33.52M-48.51%1.18M-38.47%1.43M-14.64%1.63M149.93%8.47M32.52%1.94M248.17%2.28M196.31%2.33M
Special income (charges) -------34.51M------------------0------------
-Less:Restructuring and merger&acquisition ------3.63M------------------0------------
-Less:Impairment of capital assets ------30.89M------------------0------------
Other non- operating income (expenses) -44.52%906K-38.23%5.23M-49.07%990K-48.51%1.18M-38.47%1.43M-14.64%1.63M149.93%8.47M32.52%1.94M248.17%2.28M196.31%2.33M
Income before tax 16.49%-19.53M-39.77%-116.62M-134.20%-49.41M14.03%-18.06M-18.23%-25.77M-19.69%-23.39M-2.83%-83.44M17.03%-21.1M-13.61%-21.01M-23.69%-21.8M
Income tax 95K351.77%637K517.48%636K0-96.67%1K0422.22%141K103K-9K11.11%30K
Net income 16.09%-19.63M-40.30%-117.26M-136.06%-50.04M13.99%-18.06M-18.07%-25.77M-19.58%-23.39M-2.97%-83.58M16.62%-21.2M-13.56%-21M-23.67%-21.83M
Net income continuous Operations 16.09%-19.63M-40.30%-117.26M-136.06%-50.04M13.99%-18.06M-18.07%-25.77M-19.58%-23.39M-2.97%-83.58M16.62%-21.2M-13.56%-21M-23.67%-21.83M
Minority interest income
Net income attributable to the parent company 16.09%-19.63M-40.30%-117.26M-136.06%-50.04M13.99%-18.06M-18.07%-25.77M-19.58%-23.39M-2.97%-83.58M16.62%-21.2M-13.56%-21M-23.67%-21.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.09%-19.63M-40.30%-117.26M-136.06%-50.04M13.99%-18.06M-18.07%-25.77M-19.58%-23.39M-2.97%-83.58M16.62%-21.2M-13.56%-21M-23.67%-21.83M
Basic earnings per share 32.13%-1.69-33.19%-12.48-135.40%-5.3215.04%-1.92-12.76%-2.74-2.05%-2.4982.35%-9.3728.74%-2.262.21%-2.26-10.17%-2.43
Diluted earnings per share 32.13%-1.69-33.19%-12.48-135.40%-5.3215.04%-1.92-12.76%-2.74-2.05%-2.4982.35%-9.3728.74%-2.262.21%-2.26-10.17%-2.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More